Some Methodological Considerations in the Evaluation of Drug‐Induced Extrapyramidal Disorders: A Study of EX10‐029, a New Morphanthridine Derivative
- 1 April 1972
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology and New Drugs
- Vol. 12 (4) , 142-152
- https://doi.org/10.1002/j.1552-4604.1972.tb00043.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- CONTROLLED STUDIES OF ANTIPARKINSONISM AGENTS IN THE TREATMENT OF DRUG‐INDUCED EXTRAPYRAMIDAL SYMPTOMSActa Psychiatrica Scandinavica, 1970
- A CONTROLLED COMPARISON OF THE TREATMENT OF SCHIZOPHRENIC PATIENTS WHEN TREATED ACCORDING TO THE NEUROLEPTIC THRESHOLD OR BY CLINICAL JUDGMENTActa Psychiatrica Scandinavica, 1970
- HANDWRITING CHANGES AND RESPONSE TO DRUGS—A CONTROLLED STUDYActa Psychiatrica Scandinavica, 1970
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- Drug-Induced Extrapyramidal Symptoms and Their Relations to Clinical EfficacyAmerican Journal of Psychiatry, 1967
- Extrapyramidal Side Effects and Therapeutic ResponseArchives of General Psychiatry, 1965
- TEMPORAL CHANGE IN HANDWRITING EXPANSIVENESS IN DEPRESSED AND SCHIZOPHRENIC INPATIENTSJournal of Nervous & Mental Disease, 1964
- The Brief Psychiatric Rating ScalePsychological Reports, 1962
- A preliminary report on the measurement of Parkinson's diseaseNeurology, 1960
- Studies of tone, tremor, and speech in normal persons and parkinsonian patientsNeurology, 1960